IMD COMPANIES (ICBU) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 158 252 sessions, October 10, 2025 to October 12, 2026
- Largest daily move
- +87.5% close of April 6, 2026
- 1-year change
- -54.5% closing prices, October 10, 2025 to October 12, 2026
- 1-month change
- -28.6% closing prices, September 11, 2026 to October 12, 2026
Company Description
IMD COMPANIES (OTC: ICBU) is classified in the diagnostics & research industry within the Healthcare sector and carries a market capitalization of $2.4M.
ICBU has declined 54.5% over the past year. The last closing price was $0.0005.
This page collects what Stock Titan holds for ICBU, including price data, latest news, and short interest trends.
Stock Performance
IMD COMPANIES (ICBU) closed at $0.0005 on October 12, 2026. Over the past 12 months, the price has lost 54.5%.
ICBU Metrics & Rankings
Price returns through October 12, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
IMD COMPANIES has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, crypto, partnership. View all ICBU news →
SEC Filings
Short Interest History
Short interest in IMD COMPANIES (ICBU) currently stands at 1.4 million shares, down 12.8% from the previous reporting period, representing 0.0% of the float. Since October 2025, short interest has increased by 138983700.0%.
Days to Cover History
Days to cover for IMD COMPANIES (ICBU) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 2.8 days.
ICBU Company Profile & Sector Positioning
IMD COMPANIES (ICBU) operates in the Diagnostics & Research industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing ICBU often look at related companies in the same sector, including LEVELJUMP HEALTHCARE CP (JMPHF), RENNOVA HEALTH INC (RNVA), INTERPACE BIOSCIENCES NEW (IDXG), STAGEZERO LIFE SCIENCES (SZLSF), and HYPHA LABS, INC. (FUNI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ICBU's relative position within its industry.